U.S. Secretary of Defense Pete Hegseth announced a program to screen service members for testosterone deficiency to ensure optimal performance.
The initiative seeks to establish what Hegseth called a “High-T” military. By identifying and treating hormone deficiencies, the Department of Defense intends to maximize the physical and mental readiness of its personnel.
In a social-media video released on July 15, 2026 [2], Hegseth said the goal is "ensuring you have the right testosterone levels to operate at your absolute best" [1]. The program focuses on the biological markers of readiness to maintain a competitive edge in military operations.
According to reports, the U.S. military would begin requiring all active-duty and reserve personnel aged 30 and older to undergo mandatory screening for testosterone deficiency [3]. This age threshold targets the demographic most likely to experience naturally declining hormone levels.
The announcement has drawn scrutiny from the medical community. Some experts said the proposal is a "clinical minefield" [3], suggesting that mandatory hormone screening and subsequent treatments may carry unforeseen health risks, or complexities.
Despite these concerns, the Department of Defense is moving forward with the framework. The program focuses on the intersection of endocrine health and combat effectiveness, treating hormone levels as a critical component of soldier performance.
““Ensuring you have the right testosterone levels to operate at your absolute best.””
This policy represents a shift toward biological optimization within the U.S. military. By mandating screenings for personnel aged 30 and older, the Department of Defense is treating hormonal balance as a performance metric similar to physical fitness, or marksmanship. However, the push for a “High-T” force creates a tension between operational readiness and medical caution, as clinicians warn against the broad application of hormone replacement therapy without individualized diagnostic necessity.
